He represents a state 3,000 miles away, but it is safe to say that U.S. Sen. Benjamin Cardin has a constituency in San Diego. At a Senate hearing today Cardin said he would fight for more funding for small biotechs, according to this story in the Baltimore Business Journal.

Specifically, Cardin wants 2.5 percent — or $229 million — of the $10.4 billion that the National Institutes of Health will get as part of the stimulus package to go to early-stage life science companies.

That is no doubt a popular proposal in San Diego, which is home to about 700 life science companies, most of which are small businesses.


Leave a comment

We expect all commenters to be constructive and civil. We reserve the right to delete comments without explanation. You are welcome to flag comments to us. You are welcome to submit an opinion piece for our editors to review.

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.